Meta-analysis of single agents in the chemotherapy of NSCLC: What do we want to know?

British Journal of Cancer

Volumn 84, Issue 9, 2001, Pages 1143-1145

  Bahl, A ^a   Falk, S ^a  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; VINDESINE;

CANCER SURVIVAL; CLINICAL PRACTICE; DRUG RESPONSE; EDITORIAL; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; ENDPOINT DETERMINATION; HUMANS; LUNG NEOPLASMS; META-ANALYSIS; MITOMYCIN; RESEARCH DESIGN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035805042     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1740     Document Type: Editorial

References (18)

1. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - A randomised trial with quality of life as the primary outcome
2. Chemotherapy of non-small cell lung cancer: A reappraisal and a look to the future
3. Decision framework for chemotherapeutic interventions for metastatic non-small cell lung cancer
4. Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial
5. New drug combinations in the treatment of advanced non-small cell (NSCLC) and small cell (SCLC) lung cancer
6. Mitomycin, ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life
7. Quality of life assessment in advanced cancer
8. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small cell lung cancer
9. The use of gemcitabine in non-small cell lung cancer
10. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small cell lung cancer
11. Counting the costs of chemotherapyin randomised trials in non-small cell lung cancer
12. Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer
13. Randomized comparison of two combination regimens versus minimal chemotherapy in non-small cell lung cancer: A Southeastern Cancer Study Group trial
14. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
15. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer
16. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
17. The rol of Mitomycin C in the treatment of non-small cell Lung Cancer: A systemic review with meta-analysis of the literature
18. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: A southwest oncology group study